These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 34454863)

  • 1. Impact of COVID-19 pandemic on hepatitis C elimination from the clinical microbiologist perspective. Are we ready?
    Aguilera A; Eiros JM; García F
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Nov; 39(9):475-476. PubMed ID: 34454863
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of the COVID-19 pandemic on hepatitis C diagnosis in Brazil: Is the global hepatitis C elimination strategy at risk?
    do Carmo RF; de Souza CDF
    J Hepatol; 2022 Feb; 76(2):470-472. PubMed ID: 34437907
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of the COVID-19 pandemic on HCV elimination in Spain.
    Buti M; Domínguez-Hernández R; Casado MA
    J Hepatol; 2021 May; 74(5):1246-1248. PubMed ID: 33358780
    [No Abstract]   [Full Text] [Related]  

  • 4. Altered hepatitis C testing and treatment beyond the COVID-19 pandemic.
    Karimi-Sari H; Rezaee-Zavareh MS
    Public Health; 2022 Jun; 207():e5. PubMed ID: 35568527
    [No Abstract]   [Full Text] [Related]  

  • 5. The opioid epidemic during the COVID-19 pandemic: Impact on HIV and HCV control.
    Treviño A; Soriano V
    AIDS Rev; 2021 Dec; 23(4):227. PubMed ID: 34983134
    [No Abstract]   [Full Text] [Related]  

  • 6. Similarities between the effect of SARS-CoV-2 and HCV on the cellular level, and the possible role of ion channels in COVID19 progression: a review of potential targets for diagnosis and treatment.
    Alothaid H; Aldughaim MSK; El Bakkouri K; AlMashhadi S; Al-Qahtani AA
    Channels (Austin); 2020 Dec; 14(1):403-412. PubMed ID: 33092458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreases in Hepatitis C Testing and Treatment During the COVID-19 Pandemic.
    Kaufman HW; Bull-Otterson L; Meyer WA; Huang X; Doshani M; Thompson WW; Osinubi A; Khan MA; Harris AM; Gupta N; Van Handel M; Wester C; Mermin J; Nelson NP
    Am J Prev Med; 2021 Sep; 61(3):369-376. PubMed ID: 34088556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 and viral hepatitis elimination programs: Are we stepping backward?
    Karimi-Sari H; Rezaee-Zavareh MS
    Liver Int; 2020 Aug; 40(8):2042. PubMed ID: 32319207
    [No Abstract]   [Full Text] [Related]  

  • 9. Getting ready for the next phase of the COVID-19 pandemic.
    Contreras GW
    Am J Disaster Med; 2020 Fall; 14(4):231-234. PubMed ID: 32803741
    [No Abstract]   [Full Text] [Related]  

  • 10. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world.
    Crespo J; Lazarus JV; Iruzubieta P; García F; García-Samaniego J;
    J Hepatol; 2021 Jul; 75(1):224-226. PubMed ID: 33757805
    [No Abstract]   [Full Text] [Related]  

  • 11. Should countries aim for elimination in the covid-19 pandemic?
    Lee A; Thornley S; Morris AJ; Sundborn G
    BMJ; 2020 Sep; 370():m3410. PubMed ID: 32909958
    [No Abstract]   [Full Text] [Related]  

  • 12. Getting back on the road towards tuberculosis elimination: lessons learnt from the COVID-19 pandemic.
    Furtado I; Aguiar A; Duarte R
    J Bras Pneumol; 2021 Apr; 47(2):e20210123. PubMed ID: 33950099
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic viral hepatitis C micro-elimination program using telemedicine. The Mexican experience.
    Pérez Hernández JL; Higuera de la Tijera MF; Arce Salinas CA
    Rev Esp Enferm Dig; 2021 Aug; 113(8):624-625. PubMed ID: 33569965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uprooted by COVID pandemic: National TB elimination programme needs acceleration!
    Nagaraja SB; Kelamane S; Kunjathur SM; Gurram Krishnamurthy SK
    Indian J Tuberc; 2021 Apr; 68(2):283-284. PubMed ID: 33845967
    [No Abstract]   [Full Text] [Related]  

  • 15. Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy.
    Giacomelli A; Pagani G; Conti F; Bassoli C; Galli M
    J Hepatol; 2021 Aug; 75(2):484-486. PubMed ID: 33453329
    [No Abstract]   [Full Text] [Related]  

  • 16. Elimination could be the optimal response strategy for covid-19 and other emerging pandemic diseases.
    Baker MG; Wilson N; Blakely T
    BMJ; 2020 Dec; 371():m4907. PubMed ID: 33561814
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute Hepatitis as a Rare Presentation of COVID-19.
    Khan A; Qayum I; Khan AW; Hanif M; Naeem A
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):S125-S126. PubMed ID: 34271811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral hepatitis C pandemic: Challenges and threats to its elimination.
    Krekulova L; Honzák R; Riley LW
    J Viral Hepat; 2021 May; 28(5):694-698. PubMed ID: 33550694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Nutrition on the COVID-19 Pandemic and the Impact of the COVID-19 Pandemic on Nutrition.
    Rodriguez-Leyva D; Pierce GN
    Nutrients; 2021 May; 13(6):. PubMed ID: 34064053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply.
    Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M
    J Stud Alcohol Drugs; 2020 Sep; 81(5):556-560. PubMed ID: 33028465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.